What Does xbrane-bioscience-ab Do?

Total employees123
HeadquartersSolna
Founded2008

Xbrane Biopharma AB is a commercial phase Swedish biopharmaceutical company specializing in the development and manufacturing of biosimilars. Their primary focus is on creating high-quality, cost-effective alternatives to originator biologic drugs, thereby increasing patient access to essential medicines. Xbrane leverages its patented protein production platform technology to develop a pipeline of biosimilar candidates targeting various therapeutic areas, including oncology and immunology. The company has a strategic goal to become a global leader in the biosimilars market through in-house development, manufacturing partnerships, and commercial collaborations.

Where Is xbrane-bioscience-ab's Headquarters?

xbrane-bioscience-ab officexbrane-bioscience-ab officexbrane-bioscience-ab officexbrane-bioscience-ab office
*Images sourced via web search. Rights belong to original owners

HQ Function

The headquarters in Solna serves as the central hub for Xbrane's research and development activities, corporate management, business development, and administrative functions.

Notable Features:

Located in a prominent life science cluster, providing access to talent, research institutions like the Karolinska Institutet, and a vibrant biotech ecosystem. The facilities likely include advanced laboratories for protein engineering and process development.

Work Culture:

Xbrane fosters an innovative, collaborative, and scientifically-driven work environment. The culture emphasizes quality, efficiency, and a commitment to advancing healthcare through biosimilars.

HQ Significance:

The Solna headquarters is strategically positioned to leverage Sweden's strong pharmaceutical research landscape and serves as the command center for Xbrane's global ambitions in the biosimilar space.

Values Reflected in HQ: The headquarters reflects Xbrane's commitment to scientific excellence, innovation, and precision, essential for developing complex biological drugs.

Location:

Xbrane Biopharma AB supports its functions globally through a combination of in-house expertise and strategic partnerships. Its research and development are centered in Sweden, while manufacturing capabilities are often established through collaborations with contract development and manufacturing organizations (CDMOs) in regions like Italy. Xbrane aims for global commercialization of its biosimilars, engaging in licensing and distribution agreements to reach patients worldwide. Clinical trials for their products are conducted across multiple countries to meet regulatory requirements for international markets.

Street Address:

Retzius Väg 8

City:

Solna

State/Province:

Stockholm County

Country:

Sweden

Where Else Does xbrane-bioscience-ab Operate Around the World?

Anagni, Italy

Address: Via Settevene Palo, Nuova Km 23,600, 03012 Anagni FR, Italy (Note: This is likely a primary manufacturing partner site, e.g., with AGC Biologics, rather than a direct Xbrane office. Xbrane also lists 'Xbrane Biopharma S.r.l.' in Italy.)

Serves as a key manufacturing hub for supplying European and potentially global markets, leveraging established pharmaceutical infrastructure and expertise in biologic drug production.

Buying Intent Signals for xbrane-bioscience-ab

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Who's Leading xbrane-bioscience-ab? Meet the Executive Team

As of April 2025, xbrane-bioscience-ab' leadership includes:

Martin Ă…mark - Chief Executive Officer (CEO)
Anette Lindqvist - Chief Financial Officer (CFO) & Head of Investor Relations
Siavash Bashiri - Chief Scientific Officer (CSO)
Karin Campos - Head of Regulatory Affairs
Eva-Maria Jansson - Head of Quality
Marjo Puumalainen - Head of Clinical Development & Medical Affairs
Helena Agro - Head of Legal & Compliance

Who's Investing in xbrane-bioscience-ab?

xbrane-bioscience-ab has been backed by several prominent investors over the years, including:

Serendipity Ixora AB (Part of Serendipity Group)
Swedbank Robur Fonder
Handelsbanken Fonder
Avanza Pension
Nordnet Pensionsförsäkring

What Leadership Changes Has xbrane-bioscience-ab Seen Recently?

Hire2
Exits0

Xbrane Biopharma has seen key appointments in the last 12-18 months, strengthening its financial, legal, and compliance leadership as it progresses with its biosimilar portfolio.

New Appointments:

Anette Lindqvist, Anette Lindqvist was appointed as the new CFO and Head of Investor Relations, bringing extensive financial leadership experience.
Helena Agro, Helena Agro joined Xbrane as Head of Legal & Compliance, enhancing the company's legal framework and governance.

What Technology (Tech Stack) Is Used byxbrane-bioscience-ab?

Discover the tools xbrane-bioscience-ab uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

xbrane-bioscience-ab Email Formats and Examples

Xbrane Biopharma AB commonly uses the firstname.lastname@xbrane.com email format. This is a prevalent structure in many Swedish and European companies.

firstname.lastname@xbrane.com

Format

martin.amark@xbrane.com

Example

85%

Success rate

What's the Latest News About xbrane-bioscience-ab?

Xbrane Biopharma AB • 2024-05-23

Xbrane Biopharma AB (publ) Interim report January - March 2024

Xbrane released its Q1 2024 interim report, highlighting progress in its biosimilar development programs and financial performance. Key updates included advancements in the Ximluci® (ranibizumab) commercialization and pipeline developments....more

Xbrane Biopharma AB • 2024-02-22

Xbrane Biopharma AB (publ) Year-end report 2023

The company published its full-year 2023 report, summarizing achievements such as the launch of Ximluci® in Europe, progress with FDA for US market approval, and continued development of its biosimilar pipeline, including an ustekinumab biosimilar....more

Highperformr's free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including xbrane-bioscience-ab, are just a search away.